Co-Authors
This is a "connection" page, showing publications co-authored by Carlo Salvarani and Paolo Giorgi Rossi.
Connection Strength
2.920
-
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy. Arthritis Rheumatol. 2021 01; 73(1):48-52.
Score: 0.916
-
Response to: 'COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study' by Cuceoglu et al. Ann Rheum Dis. 2020 Jul 06.
Score: 0.891
-
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study. Ann Rheum Dis. 2020 07; 79(7):986-988.
Score: 0.884
-
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia. Clin Exp Rheumatol. 2020 Nov-Dec; 38(6):1215-1222.
Score: 0.229